AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26771266 — intervention group
Group type: EXPERIMENTAL
Intervention: ETT-first technique
Number of subjects: 160
Study 26771266 — intervention group
Group type: COMPARATOR
Intervention: GlideScope-first technique
Number of subjects: 160
Study 24885388 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched Group Lifestyle Balance program (GLB) with if-then plans and mental practice
Number of subjects: 154
Study 24885388 — intervention group
Group type: COMPARATOR
Intervention: Standard Group Lifestyle Balance program (GLB)
Number of subjects: 154
Study 22420596 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol augmentation
Number of subjects: 27
Study 22420596 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol augmentation (caffeine abstainers)
Number of subjects: 27
Study 22420596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 20334955 — intervention group
Group type: EXPERIMENTAL
Intervention: hTERT immunochemical detection in adjacent, non-transformed colonic mucosa
Number of subjects: 82
Study 20334955 — intervention group
Group type: COMPARATOR
Intervention: hTERT immunochemical detection in non-affected mucosa
Number of subjects: 82
Study 20334955 — intervention group
Group type: EXPERIMENTAL
Intervention: hTERT mRNA expression in non-affected colorectal mucosa
Number of subjects: 82
Study 18779477 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.59-mg fluocinolone acetonide implant
Number of subjects: 278
Study 18779477 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.1-mg fluocinolone acetonide implant
Number of subjects: 278
Study 18779477 — intervention group
Group type: EXPERIMENTAL
Intervention: Implanted eyes (both doses)
Number of subjects: 278
Study 15310006 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS patients
Number of subjects: 27
Study 11502317 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine/pyrimethamine (25 mg/kg sulfadoxine, 1.25 mg/kg pyrimethamine) plus placebo
Number of subjects: 445
Study 11502317 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine (25 mg/kg) plus placebo
Number of subjects: 445
Study 11502317 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine plus sulfadoxine/pyrimethamine
Number of subjects: 445
Study 11502317 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine/sulfadoxine/pyrimethamine
Number of subjects: 445
Study 9430329 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 64
Study 9430329 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 64
Study 8489974 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 ml plain bupivacaine 0.5% injected as fast as possible
Number of subjects: 40
Study 8489974 — intervention group
Group type: COMPARATOR
Intervention: 3 ml plain bupivacaine 0.5% injected at a rate of 0.05 ml/sec
Number of subjects: 40
Study 3427128 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG biofeedback with high success feedback
Number of subjects: 47
Study 3427128 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG biofeedback with low success feedback
Number of subjects: 47
Study 3427128 — intervention group
Group type: EXPERIMENTAL
Intervention: True EMG biofeedback
Number of subjects: 47
Study 3427128 — intervention group
Group type: EXPERIMENTAL
Intervention: False EMG biofeedback
Number of subjects: 47
Study 3427128 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring study habits
Number of subjects: 47
Study 29679694 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Response System (RRS) intervention comprising a standardised observation and communication protocol including a pragmatic medical response strategy.
Number of subjects: 69356
Study 27376184 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrocentesis plus corticosteroid (CS) injection
Number of subjects: 24
Study 27376184 — intervention group
Group type: COMPARATOR
Intervention: Arthrocentesis alone (control group)
Number of subjects: 24
Study 27376184 — intervention group
Group type: COMPARATOR
Intervention: Comparison between CS group and control group
Number of subjects: 24
Study 24548730 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobupivicaine
Number of subjects: 60
Study 24548730 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (placebo)
Number of subjects: 60
Study 22393908 — intervention group
Group type: EXPERIMENTAL
Intervention: Calfactant aerosol
Number of subjects: 8
Study 22393908 — intervention group
Group type: COMPARATOR
Intervention: Saline aerosol
Number of subjects: 8
Study 20828359 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 cm² rivastigmine patch (13.3 mg/24 h)
Number of subjects: 0
Study 20828359 — intervention group
Group type: COMPARATOR
Intervention: 5 cm² rivastigmine patch (4.5 mg/24 h)
Number of subjects: 0
Study 19040348 — intervention group
Group type: EXPERIMENTAL
Intervention: Nepafenac 0.1% QD
Number of subjects: 212
Study 19040348 — intervention group
Group type: EXPERIMENTAL
Intervention: Nepafenac 0.1% BID
Number of subjects: 212
Study 19040348 — intervention group
Group type: EXPERIMENTAL
Intervention: Nepafenac 0.1% TID
Number of subjects: 212
Study 19040348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study 16875901 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol
Number of subjects: 10000
Study 16875901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10000
Study 12804031 — intervention group
Group type: EXPERIMENTAL
Intervention: Door-in-the-face (DITF) technique: subjects were first solicited by an exaggerated request and then for a small donation after refusal.
Number of subjects: 1607
Study 12804031 — intervention group
Group type: COMPARATOR
Intervention: Control condition: direct solicitation for a small donation without prior exaggerated request.
Number of subjects: 1607
Study 10870801 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg aspirin (daily for 1 week)
Number of subjects: 18
Study 10870801 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg aspirin (daily for 1 week)
Number of subjects: 18
Study 8784646 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 317
Study 8784646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study 1641433 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home educational intervention conducted by lay health workers (LHWs) on three occasions; education on cancer and reproductive health.
Number of subjects: 321
Study 1641433 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 321
Study 6697460 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 J truncated exponential shocks
Number of subjects: 33
Study 6697460 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 J truncated exponential shocks
Number of subjects: 33
Study 6697460 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 J truncated exponential shocks
Number of subjects: 33
Study 6697460 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 J truncated exponential shocks
Number of subjects: 33
Study 6697460 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 J to 25 J shocks
Number of subjects: 33
Study 31353695 — intervention group
Group type: EXPERIMENTAL
Intervention: Ora-pro-nobis (Pereskia aculeata) flour
Number of subjects: 0
Study 29644920 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent Medical Evaluation (IME)
Number of subjects: 9
Study 26962518 — intervention group
Group type: COMPARATOR
Intervention: Full time neutral wrist splint (Group A)
Number of subjects: 43
Study 26962518 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg Depo‐Medrol injection plus full time neutral wrist splint (Group B)
Number of subjects: 43
Study 24460811 — intervention group
Group type: EXPERIMENTAL
Intervention: Mask ventilation with chest compressions
Number of subjects: 58
Study 22806147 — intervention group
Group type: EXPERIMENTAL
Intervention: Island flap (IF group)
Number of subjects: 120
Study 22806147 — intervention group
Group type: COMPARATOR
Intervention: Bilobed flap (BF group)
Number of subjects: 120
Study 20663187 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose 75 g (300 kcals)
Number of subjects: 9
Study 20663187 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose 150 g (600 kcals)
Number of subjects: 9
Study 20663187 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid 33 g (300 kcals)
Number of subjects: 9
Study 20663187 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid 66 g (600 kcals)
Number of subjects: 9
Study 17484344 — intervention group
Group type: EXPERIMENTAL
Intervention: promethazine (25 mg) + caffeine (200 mg)
Number of subjects: 64
Study 17484344 — intervention group
Group type: COMPARATOR
Intervention: meclizine (25 mg)
Number of subjects: 64
Study 17484344 — intervention group
Group type: COMPARATOR
Intervention: Scopolamine patch (1.5 mg)
Number of subjects: 64
Study 17484344 — intervention group
Group type: COMPARATOR
Intervention: acustimulation wristband
Number of subjects: 64
Study 15218043 — intervention group
Group type: EXPERIMENTAL
Intervention: Porphyromonas gingivalis LPS stimulation
Number of subjects: 0
Study 16052902 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment process developed for a randomized controlled trial with adolescents
Number of subjects: 0
Study 16052902 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse clinicians' involvement in recruitment
Number of subjects: 0
Study 9775517 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor rotation compatible with mental rotation
Number of subjects: 0
Study 9775517 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor rotation
Number of subjects: 0
Study 9775517 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor rotation speed
Number of subjects: 0
Study 7944997 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (180 mg tid for 6 months)
Number of subjects: 89
Study 7944997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 2908751 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 75 mg twice daily
Number of subjects: 59
Study 2908751 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 150 mg at bedtime
Number of subjects: 59
Study 2908751 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 150 mg post cenam nocte
Number of subjects: 59
Study 2908751 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 300 mg post cenam nocte
Number of subjects: 59
Study 2908751 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg nocte
Number of subjects: 59
Study 2908751 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg post cenam nocte
Number of subjects: 59
Study 31941792 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-injection costoclavicular block
Number of subjects: 90
Study 31941792 — intervention group
Group type: COMPARATOR
Intervention: Single-injection costoclavicular block
Number of subjects: 90
Study 29260659 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced coverage (90% target)
Number of subjects: 24
Study 29260659 — intervention group
Group type: COMPARATOR
Intervention: Standard coverage (80% target)
Number of subjects: 24
Study 29260659 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Enhanced and Standard coverage)
Number of subjects: 24
Study 27676152 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stretching (four 30-s periods of ankle dorsiflexion and plantarflexion)
Number of subjects: 12
Study 27676152 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stretching
Number of subjects: 12
Study 24699712 — intervention group
Group type: EXPERIMENTAL
Intervention: Well Woman Exam (WWE)
Number of subjects: 0
Study 24699712 — intervention group
Group type: COMPARATOR
Intervention: Standard Intervention (SI)
Number of subjects: 0
Study 24699712 — intervention group
Group type: EXPERIMENTAL
Intervention: Four Educational Sessions (4ES)
Number of subjects: 0
Study 23737646 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy (not explicitly detailed in the abstract)
Number of subjects: 59
Study 20649936 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirodenafil 100 mg
Number of subjects: 109
Study 20649936 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 19068007 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Cognitive Behavioral Treatment (IT)
Number of subjects: 38
Study 19068007 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Treatment (GT)
Number of subjects: 38
Study 19068007 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual and Group CBT
Number of subjects: 38
Study 16912128 — intervention group
Group type: EXPERIMENTAL
Intervention: sitagliptin 25 mg
Number of subjects: 58
Study 16912128 — intervention group
Group type: EXPERIMENTAL
Intervention: sitagliptin 200 mg
Number of subjects: 58
Study 16912128 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 58
Study 12388137 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oxymetholone daily for 12 weeks
Number of subjects: 31
Study 12388137 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg oxymetholone daily for 12 weeks
Number of subjects: 31
Study 12388137 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 14748774 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 40 mg
Number of subjects: 1132
Study 9990641 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot Can 1743
Number of subjects: 40
Study 9990641 — intervention group
Group type: COMPARATOR
Intervention: Cold Can 1741
Number of subjects: 40
Study 7492458 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 litre of beverage containing 50 g alcohol
Number of subjects: 8
Study 7492458 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 8
Study 1969509 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin and mineral supplementation for seven months
Number of subjects: 86
Study 1969509 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 86
Study 7420129 — intervention group
Group type: EXPERIMENTAL
Intervention: Punctate hot stimulator (1 mm²)
Number of subjects: 0
Study 7420129 — intervention group
Group type: EXPERIMENTAL
Intervention: Punctate cold stimulator (1 mm²)
Number of subjects: 0
Study 7420129 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal stimulators (enlarged contact area)
Number of subjects: 0
Study 7420129 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot stimulator (enlarged area)
Number of subjects: 0
Study 7420129 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold stimulator (enlarged area)
Number of subjects: 0
Study 7420129 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated recognition of stimulators
Number of subjects: 0
Study 28000678 — intervention group
Group type: EXPERIMENTAL
Intervention: prebiotics (scGOS/lcFOS/glutamine)
Number of subjects: 44
Study 28000678 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 44
Study 25480319 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral analgesia with propofol GA (PPA)
Number of subjects: 386
Study 24053566 — intervention group
Group type: EXPERIMENTAL
Intervention: Happiness Route
Number of subjects: 256
Study 24053566 — intervention group
Group type: COMPARATOR
Intervention: Customized Care (Control)
Number of subjects: 256
Study 21854580 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral topiramate (n = 36) as an add-on to cognitive behavioural therapy (CBT)
Number of subjects: 216
Study 21854580 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral modafinil (n = 36) as an add-on to cognitive behavioural therapy (CBT)
Number of subjects: 216
Study 21854580 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamphetamine sustained-release (n = 36) as an add-on to cognitive behavioural therapy (CBT)
Number of subjects: 216
Study 21854580 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT) only (controls: n = 3 × 36)
Number of subjects: 216
Study 19250078 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold-tip ablation catheter (group G)
Number of subjects: 31
Study 19250078 — intervention group
Group type: COMPARATOR
Intervention: Platinum-iridium tip catheter (group PI)
Number of subjects: 31
Study 17915468 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of halotherapy (HT) and endobronchial helium‐neon laser irradiation (ELI) with traditional drug therapy (DT) in moderate persistent asthma
Number of subjects: 138
Study 17915468 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodality treatment involving DT, HT, and ELI in severe persistent asthma
Number of subjects: 138
Study 15528779 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise program (45 minutes, 3 times a week for 8 weeks)
Number of subjects: 294
Study 15528779 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise program
Number of subjects: 294
Study 15528779 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 294
Study 11677365 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin(1-7) (1000 pmol/min)
Number of subjects: 16
Study 11677365 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin(1-7) (100 pmol/min)
Number of subjects: 16
Study 11677365 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin(1-7) (10 pmol/min)
Number of subjects: 16
Study 11677365 — intervention group
Group type: EXPERIMENTAL
Intervention: NG-mononmethyl-l-arginine (co-infused with Ang(1-7))
Number of subjects: 16
Study 11677365 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 16
Study 11677365 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholine
Number of subjects: 16
Study 11677365 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside
Number of subjects: 16
Study 9043043 — intervention group
Group type: EXPERIMENTAL
Intervention: T2-weighted and dynamic contrast enhanced MRI
Number of subjects: 32
Study 9043043 — intervention group
Group type: COMPARATOR
Intervention: Contrast enhanced CT
Number of subjects: 32
Study 7966508 — intervention group
Group type: EXPERIMENTAL
Intervention: Addiction Severity Index (ASI) scores
Number of subjects: 0
Study 3286722 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 1 mg
Number of subjects: 11
Study 3286722 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 2 mg
Number of subjects: 11
Study 3286722 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 5 mg
Number of subjects: 11
Study 3286722 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 10 mg
Number of subjects: 11
Study 3286722 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 20 mg
Number of subjects: 11
Study 3286722 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 10 mg (exercise challenge)
Number of subjects: 11
Study 3286722 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 1 mg (exercise challenge)
Number of subjects: 11
Study 3286722 — intervention group
Group type: COMPARATOR
Intervention: Placebo (exercise challenge)
Number of subjects: 11
Study 31624975 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral-domain optical coherence tomography (SD-OCT)
Number of subjects: 33
Study 31624975 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal visual evoked potentials (mfVEP)
Number of subjects: 33
Study 31624975 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean inter-eye asymmetry of the RNFLt
Number of subjects: 33
Study 30202872 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive MDA (quarterly single-dose praziquantel plus albendazole daily for 3 days)
Number of subjects: 3350
Study 30202872 — intervention group
Group type: COMPARATOR
Intervention: Standard MDA (annual praziquantel plus 6 monthly single-dose albendazole)
Number of subjects: 3350
Study 29043996 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBNP and dopamine combination treatment
Number of subjects: 160
Study 29043996 — intervention group
Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 160
Study 26189942 — intervention group
Group type: EXPERIMENTAL
Intervention: CLEAR CARE(®)
Number of subjects: 74
Study 26189942 — intervention group
Group type: COMPARATOR
Intervention: renu(®) fresh™
Number of subjects: 74
Study 23011358 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg BIW
Number of subjects: 550
Study 23011358 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 10 mg BIW
Number of subjects: 550
Study 23011358 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (≤8.0 mg/week)
Number of subjects: 550
Study 21305484 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercises without electrostimulation
Number of subjects: 10
Study 21305484 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercises with electrostimulation
Number of subjects: 10
Study 19133409 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs supplementation (2.4 g/day for 24 weeks)
Number of subjects: 1533
Study 17212730 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 2 mg kg(‐1) day(‐1) for 2 days (six doses)
Number of subjects: 7
Study 17212730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 15379836 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori-infected GERD patients
Number of subjects: 101
Study 15379836 — intervention group
Group type: COMPARATOR
Intervention: Helicobacter pylori-non-infected GERD patients
Number of subjects: 101
Study 12057618 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg/AS04 hepatitis B vaccine (administered on a 0 and 6 months schedule)
Number of subjects: 230
Study 12057618 — intervention group
Group type: COMPARATOR
Intervention: Licensed hepatitis B vaccine (Engerix-B, administered on a 0, 1 and 6 months schedule)
Number of subjects: 230
Study 9839765 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil HCl (5 mg)
Number of subjects: 12
Study 9839765 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (0.25 mg)
Number of subjects: 12
Study 9839765 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of donepezil HCl (5 mg) and digoxin (0.25 mg)
Number of subjects: 12
Study 7651638 — intervention group
Group type: EXPERIMENTAL
Intervention: Interceed (TC7) Absorbable Adhesion Barrier
Number of subjects: 55
Study 7651638 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated ovaries)
Number of subjects: 55